Literature DB >> 18068918

Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.

Longxiao Liu1, Xiangning Xu.   

Abstract

In this paper, a bilayer-core osmotic pump tablet (OPT) which does not require laser drilling to form the drug delivery orifice is described. The bilayer-core consisted of two layers: (a) push layer and (b) drug layer, and was made with a modified upper tablet punch, which produced an indentation at the center of the drug layer surface. The indented tablets were coated by using a conventional pan-coating process. Although the bottom of the indentation could be coated, the side face of the indentation was scarcely sprayed by the coating solution and this part of the tablet remained at least partly uncoated leaving an aperture from which drug release could occur. Nifedipine was selected as the model drug. Sodium chloride was used as osmotic agent, polyvinylpyrrolidone as suspending agent and croscarmellose sodium as expanding agent. The indented core tablet was coated by ethyl cellulose as semipermeable membrane containing polyethylene glycol 400 for controlling the membrane permeability. The formulation of core tablet was optimized by orthogonal design and the release profiles of various formulations were evaluated by similarity factor (f(2)). It was found that the optimal OPT was able to deliver nifedipine at an approximate zero-order up to 24 h, independent on both release media and agitation rates. The preparation of bilayer-core OPT was simplified by coating the indented core tablet, by which sophisticated technology of the drug layer identification and laser drilling could be eliminated. It might be promising in the field of preparation of bilayer-core OPT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068918     DOI: 10.1016/j.ijpharm.2007.10.047

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivo evaluation.

Authors:  Jin Guan; Liying Zhou; Yusheng Pan; Haitao Han; Hongtao Xu; Weisan Pan
Journal:  Pharm Res       Date:  2009-10-27       Impact factor: 4.200

2.  Development and in vitro/in vivo evaluation of etodolac controlled porosity osmotic pump tablets.

Authors:  Ahmed Abd-Elbary; Mina Ibrahim Tadros; Ahmed Adel Alaa-Eldin
Journal:  AAPS PharmSciTech       Date:  2011-04-09       Impact factor: 3.246

Review 3.  Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery.

Authors:  Kovanya Moodley; Viness Pillay; Yahya E Choonara; Lisa C du Toit; Valence M K Ndesendo; Pradeep Kumar; Shivaan Cooppan; Priya Bawa
Journal:  Int J Mol Sci       Date:  2011-12-22       Impact factor: 5.923

4.  Feasibility of optimizing trimetazidine dihydrochloride release from controlled porosity osmotic pump tablets of directly compressed cores.

Authors:  Basant A Habib; Randa T Abd El Rehim; Samia A Nour
Journal:  J Adv Res       Date:  2013-06-11       Impact factor: 10.479

5.  Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.

Authors:  Zongzhe Zhao; Chao Wu; Ying Zhao; Yanna Hao; Ying Liu; Wenming Zhao
Journal:  Int J Nanomedicine       Date:  2015-03-03

6.  Double-layered osmotic pump controlled release tablets of actarit: In vitro and in vivo evaluation.

Authors:  Yuenan Li; Hao Pan; Hongliang Duan; Jianting Chen; Zhihong Zhu; Jingxin Fan; Pingfei Li; Xinggang Yang; Weisan Pan
Journal:  Asian J Pharm Sci       Date:  2018-08-19       Impact factor: 6.598

7.  Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.

Authors:  Wen Lin; Yinke Li; Qiongzhi Shi; Xiangru Liao; Yuan Zeng; Wei Tian; Xiangyang Xie; Hui Liu
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.